Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06583148 · ClinicalTrials.gov registry record · NA
A Smoke-Free Home Intervention in Tribal Communities
A NA study of Tobacco-Related Carcinoma, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 575
- Enrollment target
- 1
- Study location
NCT06583148: Recruiting NA study of Tobacco-Related Carcinoma, sponsored by Emory University.
NCT06583148 is a NA study of Tobacco-Related Carcinoma that is actively recruiting participants, run by Emory University. The registered enrollment target is 575 participants, below the 1,452-participant average among 10 other Tobacco-Related Carcinoma trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06583148, a NA study of Tobacco-Related Carcinoma, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 575 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial evaluates a smoke-free home intervention for reducing exposure to secondhand smoke from commercial tobacco in homes of participants who live in rural tribal communities. Smoke-free homes are an innovative and relatively untapped strategy for cancer prevention in rural tribal communities. Smoke-free policies, including those that target homes, can reduce exposure to secondhand smoke and support smoking cessation. Rural and racial/ethnic inequities intersect to increase tobacco-related harms among Indigenous populations. A smoke-free home program may improve the health of the household as well as impact smoking behavior among the family unit by reducing secondhand smoke exposure.
Primary Outcome
Which statement best describes rules about smoking inside your home? There are no rules about smoking inside your home? Smoking is not allowed anywhere inside your home? Smoking is allowed in some places or at some times in your home? Smoking is allowed anywhere inside your home? Those answering that smoking is not allowed anywhere inside their home are classified as having a smoke-free home. It will be self-reported \& measured using air nicotine monitor from a subset of 20% participants to ass
Conditions Studied
Interventions
- BEHAVIORAL Smoking Cessation Intervention
- OTHER Survey Administration
- OTHER Best Practice
Study Locations (1)
Georgia
- Emory University Hospital/Winship Cancer Institute - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 575 participants |
| Start Date | 2024-11-15 |
| Est. Completion | 2029-01-31 |
| Phase | NA |
What NCT06583148 shows while recruiting
NCT06583148 is an interventional study that assigns participants to a tested intervention. The registered 575 participants enrollment target is mid-sized for trials with a published cap, below the 1,452-participant average among 10 other Tobacco-Related Carcinoma trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Tobacco-Related Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Smoking Cessation Intervention is the first listed.
NCT06583148 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06583148 about?
NCT06583148 is a clinical study titled "A Smoke-Free Home Intervention in Tribal Communities". This clinical trial evaluates a smoke-free home intervention for reducing exposure to secondhand smoke from commercial tobacco in homes of participants who live in rural tribal communities. Smoke-free homes are an innovative and relatively untapped strategy for cancer prevention in rural tribal comm...
What is the current status of trial NCT06583148?
This trial is currently recruiting. It is a NA study. The enrollment target is 575 participants. The study started on 2024-11-15. Estimated completion is 2029-01-31.
What conditions does trial NCT06583148 study?
This clinical trial studies the following conditions: Tobacco-Related Carcinoma.
What interventions are being tested in trial NCT06583148?
The interventions under investigation include: Smoking Cessation Intervention (BEHAVIORAL), Survey Administration (OTHER), Best Practice (OTHER).
Who is sponsoring clinical trial NCT06583148?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06583148 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco-Related Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06583148's enrollment target sits among peer trials
575 6th of 10 higher than 5 of 10 other Tobacco-Related Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco-Related Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Studying the Health Perceptions and Social Behaviors of Graduate Students at the Ohio State University for the Development of Effective Oral Nicotine Pouch Addictive Risk Communication
RECRUITING · NA
-
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
RECRUITING · NA
-
Manipulating E-Cigarette Nicotine to Promote Public Health
RECRUITING · NA
-
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
RECRUITING · NA
-
Healthy Family Project: Tobacco Use and Smoke Exposure in Asian American Communities
RECRUITING · NA
-
Effects of Tobacco Cut and Nicotine Form on the Abuse Liability of Moist Snuff
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02610439 · 575 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
- NCT05919264 · 575 participants · Phase 1
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- NCT06883175 · 575 participants · NA
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
- NCT04931810 · 576 participants · NA
Urban and Reservation Implementation of All Nations Breath of Life
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI